Inventor · disambiguated record
Xiao Zhu
Also filed as: ZHU XIAO · ZHU XIAO-XIA
15 granted patents·29 pending applications·145 citations·filing 1997–2025
91Inventor score
Files withKYMERA THERAPEUTICS INC30BRISTOL MYERS SQUIBB CO6CELGENE CORP2GULATI POONAM S1KYMERA THERAPEUTIS INC1
Top patents by PatentIndex Score
44 records- 0197US7241586B2Polypeptide formulations and methods for making, using and characterizing themMEDTRONIC MINIMED INC·Filed 2005·Granted Jul 10, 2007·97 cites·4 claims
- 0296US11591332B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·9 cites·19 claims
- 0395US12091411B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·5 cites·9 claims
- 0494US12150995B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·4 cites·15 claims
- 0594US11932624B2MDM2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·2 cites·30 claims
- 0690US11679109B2SMARCA degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Jun 20, 2023·3 cites·16 claims
- 0788US10294229B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 21, 2019·9 cites·13 claims
- 0879US11351164B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 7, 2022·1 cites·17 claims
- 0976US12097261B2CDK2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·12 claims
- 1076US2025011325A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1175US11203592B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 21, 2021·1 cites·20 claims
- 1275US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1375US2025121073A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1475US2023234953A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1575US2025114461A1Cdk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1674US2025333417A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1773US2024024318A1Smarca degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1867US2023135894A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1966US2023173078A1Smarca degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2065US2023096599A1Irak degraders and uses thereofKYMERA THERAPEUTIS INC·Filed 2021·Application pending·0 cites
- 2165US2025275970A1Smarca degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2264US2024174665A1Cdk2 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2363US2025214969A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2462US2025375526A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2562US2024173419A1Cdk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2662US2025205342A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2760US2025179075A1Mk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2860US2025051338A1Tyk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2959US8173765B2Polymers, uses and methods of manufacture thereofZHU XIAO-XIA·Filed 2008·Granted May 8, 2012·1 cites·46 claims
- 3058US2024343724A1Smarca degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3158US2025213586A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3257US2025346592A1Heterocyclic pad4 inhibitorsCELGENE CORP·Filed 2023·Application pending·0 cites
- 3357US2024293423A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3456US11667663B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 6, 2023·0 cites·3 claims
- 3556US2025170248A1Smarca degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3656US2023416242A1Double degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3755US5955068ABiodegradable polanhydrides derived from dimers of bile acids, and use thereof as controlled drug release systemsUNIV MONTREAL·Filed 1997·Granted Sep 21, 1999·13 cites·18 claims
- 3855US2024016942A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3953US2011144281A1Amphiphilic polymers having a cholane coreVALORISATION RECH SOC EN COMMANDITE·Filed 2008·Application pending·0 cites
- 4053US2008113443A1Polypeptide formulations and methods for making, using and characterizing themGULATI POONAM S·Filed 2007·Application pending·0 cites
- 4153US2025353848A1Heterocyclic pad4 inhibitorsCELGENE CORP·Filed 2023·Application pending·0 cites
- 4251US2023219945A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4350US11066392B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·0 cites·24 claims
- 4446US12473304B2Heterocyclic PAD4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 18, 2025·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Xiao Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →